Physician profile
Lynne A Hackert
NPI 1952339111
$12,848.37
in general payments reported to CMS, 2019-2025
20 companies · $1,522 in 2025
The $1,522 reported for 2025 was more than what 80% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,618 · 2020: $2,138 · 2021: $739 · 2022: $1,470 · 2023: $1,845 · 2024: $2,516 · 2025: $1,522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,971 · Travel and Lodging: $1,673 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,971.32 |
| Travel and Lodging | $1,673.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $238.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $5,340.06 | 2019-2025 | |
| Mentor Worldwide LLC | $2,399.59 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Stryker Corporation | $907.80 | 2019-2020 | |
| Sientra, INC. | $904.03 | 2020-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Tela Bio, INC. | $806.29 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medical Device Business Services, INC. | $684.36 | 2024 | |
| Integra Lifesciences Corporation | $331.43 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Allergan, INC. | $281.40 | 2019-2021 | |
| Innovation Technologies INC | $224.93 | 2020-2024 | Irrisept |
| Tepha INC | $163.51 | 2019 | |
| Abbvie INC. | $144.45 | 2023-2025 | |
| Baudax Bio INC. | $126.26 | 2021 | |
| Avita Medical Americas, LLC | $103.98 | 2024 | |
| Davol INC. | $96.01 | 2023 | Phasix Mesh |
| Kerecis Limited | $89.43 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $81.78 | 2020 | |
| Lifenet Health | $71.17 | 2025 | Theragenesis Wound Matrix |
| Becton, Dickinson and Company | $45.02 | 2025 | Phasix Mesh |
| Daiichi Sankyo INC. | $29.23 | 2025 | Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $17.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynne Hackert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.